FDA Says Supplement AERs Will Be Subject To Lower Threshold Before Action

FDA will continue to take actions against dietary supplement products prompted by a lower tolerance for adverse events than for other types of products, a policy reflected in its request for a recall the Hydroxycut weight-loss product line